1-(1-(tert-butylcarbamoyl)piperidin-4-yl)-N-(4-(6-methoxypyrazolo[1,5-a]pyridine-3-carboxamido)-3-methylphenyl)-1H-indazole-3-carboxamide

ID: ALA4582324

PubChem CID: 155562023

Max Phase: Preclinical

Molecular Formula: C34H38N8O4

Molecular Weight: 622.73

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccccc45)cc3C)cnn2c1

Standard InChI:  InChI=1S/C34H38N8O4/c1-21-18-22(10-12-27(21)37-31(43)26-19-35-41-20-24(46-5)11-13-28(26)41)36-32(44)30-25-8-6-7-9-29(25)42(39-30)23-14-16-40(17-15-23)33(45)38-34(2,3)4/h6-13,18-20,23H,14-17H2,1-5H3,(H,36,44)(H,37,43)(H,38,45)

Standard InChI Key:  DEGODTVDGRTRCG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
   14.3655  -29.3322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3643  -30.1517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0724  -30.5607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0706  -28.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7792  -29.3286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7840  -30.1472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5640  -30.3956    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0414  -29.7305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5563  -29.0711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5502  -28.2509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2548  -27.8370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8395  -27.8475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8334  -27.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5401  -26.6201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5344  -25.8037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8231  -25.3996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1161  -25.8178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1253  -26.6328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8159  -24.5824    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5201  -24.1676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5129  -23.3505    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2313  -24.5700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3245  -25.3817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1253  -25.5446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9755  -24.2309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5243  -24.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3192  -24.6601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5664  -23.8831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0126  -23.2801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2198  -23.4574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4661  -26.2864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9904  -26.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3272  -27.6927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1407  -27.7740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6164  -27.1084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2785  -26.3614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4779  -28.5184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0019  -29.1826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2912  -28.5985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6284  -29.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4416  -29.4231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1523  -30.0071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8384  -30.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4224  -27.0497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6563  -30.5597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9489  -30.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  4  1  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 26  1  0
 25 22  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 24 31  1  0
 34 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  1  0
 40 42  1  0
 40 43  1  0
 18 44  1  0
  2 45  1  0
 45 46  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4582324

    ---

Associated Targets(Human)

CSK Tchem Tyrosine-protein kinase CSK (2395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ZAP70 Tchem Tyrosine-protein kinase ZAP-70 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 622.73Molecular Weight (Monoisotopic): 622.3016AlogP: 5.65#Rotatable Bonds: 6
Polar Surface Area: 134.89Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 0.77CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 5Heavy Atoms: 46QED Weighted: 0.22Np Likeness Score: -1.73

References

1. O'Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D..  (2019)  Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase.,  10  (10): [PMID:31620238] [10.1021/acsmedchemlett.9b00354]

Source